Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Azenta, Inc.
  6. Summary
    AZTA   US1143401024

AZENTA, INC.

(AZTA)
  Report
Delayed Quote. Delayed Nasdaq - 01/25 04:00:01 pm
79.32 USD   -2.88%
01/24Azenta Life Sciences Announces Fiscal 2022 First Quarter Earnings Conference Call and Webcast
PR
01/12AZENTA : Investor Overview January 2022
PU
01/10Azenta to Seek M&A
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
80.7(c) 79.76(c) 77.67(c) 81.67(c) 79.32(c) Last
710 682 849 398 615 354 940 612 978 691 Volume
-0.75% -1.16% -2.62% +5.15% -2.88% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 587 M - -
Net income 2022 -5,60 M - -
Net Debt 2022 - - -
P/E ratio 2022 -992x
Yield 2022 0,50%
Sales 2023 694 M - -
Net income 2023 59,6 M - -
Net Debt 2023 - - -
P/E ratio 2023 121x
Yield 2023 0,50%
Capitalization 5 856 M 5 856 M -
Capi. / Sales 2022 9,97x
Capi. / Sales 2023 8,44x
Nbr of Employees 2 800
Free-Float -
More Financials
Company
Azenta, Inc. (Azenta), formerly Brooks Automation, Inc., is a provider of life sciences solutions worldwide, enabling therapies to market faster. Azenta provides a full suite of cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's... 
Sector
Semiconductor Equipment & Testing
Calendar
01/24 | 10:00amShareholder meeting
More about the company
Ratings of Azenta, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about AZENTA, INC.
01/24Azenta Life Sciences Announces Fiscal 2022 First Quarter Earnings Conference Call and W..
PR
01/12AZENTA : Investor Overview January 2022
PU
01/10Azenta to Seek M&A
CI
01/06Azenta Appoints Matthew McManus as COO
MT
01/06Azenta Life Sciences Names Matthew McManus Chief Operating Officer
PR
01/06Azenta Life Sciences Names Matthew McManus as Chief Operating Officer, Effective Januar..
CI
01/06Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems
AQ
2021Azenta Life Sciences to Participate in the 40th Annual J.P. Morgan Conference
PR
2021Azenta Life Sciences to Participate in the 24th Annual Needham Virtual Growth Conferenc..
PR
2021AZENTA : Investor Overview December 2021
PU
2021BROOKS AUTOMATION, INC. : Ex-dividend day for
FA
2021Brooks Automation Completes Name Change to Azenta
MT
2021AZENTA, INC. (NASDAQ : AZTA) Announces Completion of Corporate Name and Stock Ticker Symbo..
PU
2021AZENTA, INC. (NASDAQ : AZTA) Announces Completion of Corporate Name and Stock Ticker Symbo..
PR
2021Brooks Automation, Inc. will Change its Ticker to AZTA from BRKS
CI
More news
News in other languages on AZENTA, INC.
01/10Azenta cherche à réaliser une fusion-acquisition
01/06Azenta Life Sciences nomme Matthew McManus au poste de directeur de l'exploitation, à c..
2021Brooks Automation change de nom et devient Azenta
2021Brooks Automation change de marque pour devenir Azenta
2021Le BPA ajusté et le chiffre d'affaires de Brooks Automation augmentent au quatrième tri..
More news
Analyst Recommendations on AZENTA, INC.
More recommendations
Chart AZENTA, INC.
Duration : Period :
Azenta, Inc. Technical Analysis Chart | AZTA | US1143401024 | MarketScreener
Technical analysis trends AZENTA, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 79,32 $
Average target price 143,25 $
Spread / Average Target 80,6%
EPS Revisions
Managers and Directors
Stephen S. Schwartz Chief Executive Officer & Executive Director
Lindon G. Robertson Chief Financial Officer & Executive Vice President
Joseph R. Martin Independent Director
Matthew F. McManus Chief Operating Officer
Alfred Woollacott Independent Director
Sector and Competitors
1st jan.Capi. (M$)
AZENTA, INC.-23.07%5 856
ASML HOLDING N.V.-18.57%269 021
LAM RESEARCH CORPORATION-18.20%87 551
TOKYO ELECTRON LTD-11.83%79 892
ENTEGRIS, INC.-16.12%16 643
ASE TECHNOLOGY HOLDING CO., LTD.-6.10%15 662